Viking Therapeutics, Inc. (VKTX) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 0 | 94K | 114K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 0 | -94K | -114K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 100% | - | - |
| Operating Expenses | 164.13M | 164.74M | 98.56M | 74.57M | 55.47M | 46.24M | 36.56M | 34.05M | 34.07M | 29.29M | 27.27M | 23.74M | 20.54M | 20.28M | 16.2M | 17.63M | 16.25M | 12.51M | 13.4M | 15.54M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 13.97M | 11.28M | 8.61M | 14.42M | 14.08M | 15.25M | 13.77M | 10.29M | 9.97M | 8.78M | 8.89M | 9.82M | 9.53M | 4.11M | 4.24M | 4.09M | 3.69M | 2.66M | 2.61M | 2.74M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 150.15M | 153.46M | 89.95M | 60.15M | 41.39M | 30.99M | 22.79M | 23.77M | 24.1M | 20.5M | 18.38M | 13.92M | 11.01M | 16.18M | 11.96M | 13.54M | 12.55M | 9.85M | 10.79M | 12.8M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -164.13M | -164.74M | -98.56M | -74.57M | -55.47M | -46.24M | -36.56M | -34.05M | -34.07M | -29.29M | -27.27M | -23.74M | -20.54M | -20.28M | -16.2M | -17.63M | -16.25M | -12.51M | -13.4M | -15.54M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -195.89% | -256.28% | -169.62% | -118.99% | -62.79% | -57.89% | -34.08% | -43.45% | -65.91% | -44.38% | -68.34% | -34.65% | -26.42% | -62.13% | -20.84% | -13.45% | -14.18% | -11.05% | -36.17% | -46.53% |
| EBITDA | -164.13M | -164.64M | -98.45M | -74.46M | -55.36M | -46.13M | -36.47M | -33.98M | -34M | -29.21M | -27.19M | -23.67M | -20.46M | -20.21M | -16.05M | -17.63M | -16.17M | -12.43M | -13.33M | -15.47M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | -196.48% | -256.93% | -169.95% | -119.14% | -62.82% | -57.91% | -34.12% | -43.57% | -66.13% | -44.53% | -69.38% | -34.24% | -26.58% | -62.55% | -20.45% | -13.98% | -14.21% | -11.08% | -36.38% | -46.78% |
| D&A (Non-Cash Add-back) | 0 | 94K | 114K | 112K | 111K | 110K | 87K | 75K | 74K | 74K | 73K | 73K | 72K | 72K | 142K | 0 | 77K | 76K | 75K | 73K |
| EBIT | -164.13M | -164.74M | -98.56M | -74.57M | -55.47M | -46.24M | -36.56M | -34.05M | -34.07M | -29.29M | -27.27M | -23.74M | -20.54M | -20.28M | -16.2M | -17.63M | -16.25M | -12.51M | -13.4M | -15.54M |
| Net Interest Income | 5.8M | 7.04M | 7.76M | 9.01M | 9.84M | 10.82M | 11.51M | 11.8M | 6.72M | 4.68M | 4.73M | 4.51M | 1.01M | 724K | 423K | 241K | 154K | 147K | 125K | 160K |
| Interest Income | 5.8M | 7.04M | 7.77M | 9.03M | 9.86M | 10.84M | 11.53M | 11.82M | 6.75M | 4.71M | 4.73M | 4.55M | 1.03M | 732K | 450K | 253K | 154K | 159K | 125K | 181K |
| Interest Expense | 0 | 0 | 8K | 24K | 24K | 24K | 24K | 18K | 28K | 26K | 2K | 32K | 28K | 8K | 27K | 12K | 0 | 12K | 0 | 21K |
| Other Income/Expense | 5.8M | 7.08M | 7.77M | 9.01M | 9.84M | 10.82M | 11.62M | 11.8M | 6.72M | 4.68M | 4.73M | 4.51M | 1.01M | 724K | 423K | 199K | 142K | 154K | 160K | 160K |
| Pretax Income | -158.32M | -157.66M | -90.79M | -65.56M | -45.63M | -35.42M | -24.94M | -22.25M | -27.36M | -24.61M | -22.53M | -19.23M | -19.53M | -19.56M | -15.77M | -17.43M | -16.1M | -12.36M | -13.24M | -15.38M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -158.32M | -157.66M | -90.79M | -65.56M | -45.63M | -35.42M | -24.94M | -22.25M | -27.36M | -24.61M | -22.53M | -19.23M | -19.53M | -19.56M | -15.77M | -17.43M | -16.1M | -12.36M | -13.24M | -15.38M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -246.98% | -345.16% | -264.02% | -194.66% | -66.8% | -43.94% | -10.68% | -15.73% | -40.06% | -25.8% | -42.86% | -10.29% | -21.29% | -58.3% | -19.1% | -13.33% | -14.94% | -12.86% | -42.58% | -60.69% |
| Net Income (Continuing) | -158.32M | -157.66M | -90.79M | -65.56M | -45.63M | -35.42M | -24.94M | -22.25M | -27.36M | -24.61M | -22.53M | -19.23M | -19.53M | -19.56M | -15.77M | -17.43M | -16.1M | -12.36M | -13.24M | -15.38M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -1.37 | -1.38 | -0.81 | -0.58 | -0.41 | -0.32 | -0.22 | -0.20 | -0.26 | -0.25 | -0.23 | -0.19 | -0.24 | -0.25 | -0.20 | -0.23 | -0.21 | -0.16 | -0.17 | -0.20 |
| EPS Growth % | -234.15% | -331.25% | -268.18% | -190% | -57.69% | -28% | 4.35% | -5.26% | -8.33% | 0% | -15% | 17.39% | -14.29% | -56.25% | -17.65% | -15% | -10.53% | -6.67% | -30.77% | -53.85% |
| EPS (Basic) | -1.37 | -1.38 | -0.81 | -0.58 | -0.41 | -0.32 | -0.22 | -0.20 | -0.26 | -0.25 | -0.23 | -0.19 | -0.24 | -0.25 | -0.20 | -0.23 | -0.21 | -0.16 | -0.17 | -0.20 |
| Diluted Shares Outstanding | 115.57M | 114M | 112.32M | 112.13M | 112.07M | 111.34M | 110.91M | 110.39M | 103.46M | 100.11M | 99.85M | 99.01M | 78.35M | 76.59M | 76.51M | 77.03M | 77.41M | 76.91M | 78.01M | 77.9M |
| Basic Shares Outstanding | 115.57M | 114M | 112.32M | 112.13M | 112.07M | 111.34M | 110.91M | 110.39M | 103.46M | 100.11M | 99.85M | 99.01M | 78.35M | 76.59M | 76.5M | 77.03M | 77.41M | 76.91M | 78.01M | 77.9M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |